STAGE III GASTRIC ADENOCARCINOMA
Clinical trials for STAGE III GASTRIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new STAGE III GASTRIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for STAGE III GASTRIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to keep stomach cancer from returning after surgery
Disease control Recruiting nowThis study tests whether adding the targeted drug disitamab vedotin to standard chemotherapy (SOX) after surgery can help prevent stomach cancer from coming back in people with HER2-positive stage III disease. About 124 adults who had complete tumor removal with extensive lymph n…
Matched conditions: STAGE III GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New chemo combo could improve outcomes for stomach cancer patients
Disease control Recruiting nowThis phase 3 trial tests whether a chemotherapy combination of oxaliplatin plus S-1 works as well as or better than docetaxel plus S-1 for stage III gastric cancer patients who have had surgery. About 387 adults aged 18 to 80 will be randomly assigned to one of the two treatments…
Matched conditions: STAGE III GASTRIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC